Allianz Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-97,400
| Closed | -$642K | – | 1746 |
|
2023
Q2 | $642K | Buy |
+97,400
| New | +$642K | ﹤0.01% | 1260 |
|
2022
Q1 | – | Sell |
-28,194
| Closed | -$442K | – | 2121 |
|
2021
Q4 | $442K | Sell |
28,194
-1
| -0% | -$16 | ﹤0.01% | 1860 |
|
2021
Q3 | $484K | Sell |
28,195
-13,946
| -33% | -$239K | ﹤0.01% | 1794 |
|
2021
Q2 | $907K | Buy |
+42,141
| New | +$907K | ﹤0.01% | 1508 |
|
2020
Q2 | – | Sell |
-55,833
| Closed | -$578K | – | 2042 |
|
2020
Q1 | $578K | Sell |
55,833
-74,199
| -57% | -$768K | ﹤0.01% | 1595 |
|
2019
Q4 | $2.13M | Buy |
130,032
+73,251
| +129% | +$1.2M | ﹤0.01% | 1438 |
|
2019
Q3 | $754K | Sell |
56,781
-83,591
| -60% | -$1.11M | ﹤0.01% | 1769 |
|
2019
Q2 | $1.98M | Sell |
140,372
-1,687
| -1% | -$23.8K | ﹤0.01% | 1551 |
|
2019
Q1 | $2.61M | Sell |
142,059
-829
| -0.6% | -$15.3K | ﹤0.01% | 1479 |
|
2018
Q4 | $3.73M | Sell |
142,888
-5,475
| -4% | -$143K | ﹤0.01% | 1263 |
|
2018
Q3 | $3.41M | Buy |
148,363
+12,903
| +10% | +$296K | ﹤0.01% | 1410 |
|
2018
Q2 | $2.58M | Sell |
135,460
-758
| -0.6% | -$14.4K | ﹤0.01% | 1436 |
|
2018
Q1 | $2.3M | Buy |
136,218
+3,903
| +3% | +$65.8K | ﹤0.01% | 1458 |
|
2017
Q4 | $2.01M | Sell |
132,315
-1,507
| -1% | -$22.9K | ﹤0.01% | 1531 |
|
2017
Q3 | $2.4M | Sell |
133,822
-1,115
| -0.8% | -$20K | ﹤0.01% | 1439 |
|
2017
Q2 | $2.2M | Buy |
134,937
+5,451
| +4% | +$88.8K | ﹤0.01% | 1449 |
|
2017
Q1 | $1.81M | Sell |
129,486
-10,594
| -8% | -$148K | ﹤0.01% | 1530 |
|
2016
Q4 | $2.23M | Sell |
140,080
-12,384
| -8% | -$198K | ﹤0.01% | 1448 |
|
2016
Q3 | $2.54M | Buy |
152,464
+104,324
| +217% | +$1.74M | ﹤0.01% | 1413 |
|
2016
Q2 | $539K | Buy |
+48,140
| New | +$539K | ﹤0.01% | 1759 |
|
2015
Q2 | – | Sell |
-23,230
| Closed | -$216K | – | 2024 |
|
2015
Q1 | $216K | Buy |
+23,230
| New | +$216K | ﹤0.01% | 1782 |
|